Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Asset Utilization Ratio (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.01 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio changed N/A to 0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, changed N/A year-over-year, with the annual reading at 0.0 for FY2023, 79.94% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.01 at Crescent Biopharma, up from 0.01 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.02 in Q2 2021, with the low at 0.01 in Q2 2025.
  • Average Asset Utilization Ratio over 4 years is 0.0, with a median of 0.0 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio tumbled 92.49% in 2022, then grew 4.69% in 2023.
  • Over 4 years, Asset Utilization Ratio stood at 0.01 in 2021, then crashed by 87.86% to 0.0 in 2022, then fell by 10.73% to 0.0 in 2023, then tumbled by 556.27% to 0.01 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.01, 0.01, and 0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.